Trial · NCT02418000
Registered outcomes23
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
21 to 23 of 23
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Secondary | Number of Participants With Suppression of in pERK by PIA 24 Hours Post-dose | Cycle 1 Day 1, 24 hours post-dose. | Blood assay: Plasma inhibitory assay (PIA) measuring pERK in blood at 24 hours post-dose |
| Secondary | Number of Participants With Suppression of pFLT3 by PIA at 4 Hours Post-dose | Cycle 1 Day 1, 4 hours post-dose. | Blood assay: Plasma inhibitory assay (PIA) measuring pFLT3 in blood at 4 hours post-dose |
| Secondary | Number of Participants With Suppression of pFLT3 by PIA at 24 Hours Post-dose | Cycle 1 Day 1, 24 hours post-dose. | Blood assay: Plasma inhibitory assay (PIA) measuring pFLT3 in blood at 24 hours post-dose |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02418000/registered?page=2